WGS — GeneDx Holdings Corp.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1818331 ·
Last close
$47.29
Market Cap
$1.42B
52W High
$170.87
52W Low
$32.21
ADV30
1,016,818
Next earnings
—
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 123,101,000 86,060,000 -9,528,000 -12,327,000 526,484,000 96,139,000 281,795,000
Jun 2026 114,440,000 78,238,000 -15,243,000 -17,740,000 481,486,000 60,317,000 237,265,000
Mar 2026 102,254,000 68,211,000 -26,184,000 -63,316,000 506,301,000 93,924,000 252,177,000
Dec 2025 120,989,000 84,268,000 -14,235,000 -17,666,000 523,710,000 104,997,000 215,528,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-75,078,000
Investing CF
$-41,375,000
Financing CF
$116,627,000
CapEx
$-26,138,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.44
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,466,878,000
Inventory
$21,703,000
Receivables
$92,131,000
ST Investments
$73,979,000
EBIT TTM
$-103,532,000
Pretax Income TTM
$-111,208,000
Interest Exp TTM
$4,243,000
Analysts
8

Yahoo Snapshot (yfinance, live)

Total Revenue
$460,784,000
EBITDA
$-36,656,000
Free Cash Flow
$-70,288,000
Enterprise Value
$1,614,925,440
Total Cash
$170,118,000
Total Debt
$215,384,000
Shares Out
29,972,493
Trailing EPS
$-3.76
Book Value
$8.17
ROE
-41.4%
ROA
-7.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 427,539,000 -13,077,000 -21,021,000 523,710,000 215,528,000 308,182,000 33,279,000
Dec 2024 305,450,000 -23,213,000 -52,286,000 419,380,000 174,133,000 245,247,000 -28,496,000
Dec 2023 202,566,000 -170,194,000 -175,767,000 418,756,000 190,739,000 228,017,000 -180,147,000
Dec 2022 234,694,000 -457,507,000 -548,980,000 490,942,000 237,237,000 253,705,000 -319,155,000

TTM Snapshot

Revenues TTM
$454,426,000
NetIncome TTM
$-106,357,000
OpCashFlow TTM
—
Assets (Latest)
$481,486,000
Forward EPS
$1.26

Peers — same industry

TickerNameMarket CapLastDaily %
LMRI Lumexa Imaging Holdings, Inc. $1.41B $14.63 —
USPH U S PHYSICAL THERAPY INC /NV $1.45B $97.34 —
TDOC Teladoc Health, Inc. $1.55B $8.49 —
INNV InnovAge Holding Corp. $1.29B $9.42 —
PNTG Pennant Group, Inc. $1.28B $36.50 —

News headlines (Yahoo Finance, 1h cache)

GeneDx Holdings (WGS) Says Sequencing Guided Care In More Than 60% Of Patients
2026-11-13 10:15 · Yahoo
Who Is Paying For GeneDx's Cash Burn?
2026-11-12 17:44 · Yahoo
GeneDx to Participate in Upcoming Investor Conferences
2026-11-11 21:05 · Yahoo
GeneDx (WGS) Stock Looks About Right After Fresh Sales Progress
2026-11-11 11:12 · Yahoo
Is GeneDx Holdings (WGS) Undervalued After Third Quarter 2026 Results?
2026-11-11 09:11 · Yahoo
Why GeneDx Holdings Stock Just Dropped 16.6%
2026-11-10 22:06 · Yahoo
GeneDx Holdings Corp. Q3 2026 Earnings Call Summary
2026-11-10 13:30 · Yahoo
GeneDx (WGS) Q3 2026 Earnings Call Transcript
2026-11-10 07:02 · Yahoo
GeneDx Holdings Corp (WGS) (Q3 2026) Earnings Call Highlights: Revenue Hits $123. ...
2026-11-10 05:10 · Yahoo
GeneDx Q3 Earnings Call Highlights
2026-11-10 02:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.